President Donald Trump just dropped a bombshell that could shake up the healthcare world. On Friday, he declared his intention to haul health insurance giants into a room and push for massive cuts to costs that have long burdened American families, Newsmax reported.
Trump’s latest plan, announced during a live broadcast on Newsmax and its free streaming platform Newsmax2, centers on a meeting with insurance companies to tackle the crushing expense of healthcare.
Following a recent breakthrough with nine major drugmakers to slash pharmaceutical prices, Trump is now turning his sights on insurers. This comes after a total of 14 pharmaceutical companies, including heavyweights like Amgen, Merck, and Novartis, agreed to deals with the administration amid tariff pressures. Three others—AbbVie, Johnson & Johnson, and Regeneron—are reportedly close to making their own price-cut announcements, according to The Washington Post.
“I’ll bet you if I called a meeting of the insurance companies, the companies that are involved with healthcare costs, I would be willing to bet that they would reduce their prices very, very substantially,” Trump said during his Newsmax broadcast.
The meeting could happen as soon as next week in Florida or early in the new year at the White House. Timing aside, the message is clear: Trump isn’t playing games with an industry often criticized for prioritizing bottom lines over patients.
Trump also hinted at a radical alternative to dealing with insurers. “Now, my initial thought, and this is what I want to do as of right now, this is the alternative, is that all of the billions and billions, ultimately trillions and trillions of dollars that’s paid to these companies, we’re going to pay directly to the people,” he stated on Newsmax.
Insurers aren’t exactly cheering from the sidelines. They’ve been pushing back against Congress and the Trump administration over proposed Medicaid cuts in the One Big Beautiful Bill Act, as reported by The Hill.
Meanwhile, the insurance lobby has been fighting tooth and nail to keep enhanced Affordable Care Act subsidies alive, set to expire at year’s end. Democrats, who created these subsidies during the pandemic and extended them in 2022, warn of premium hikes if they lapse. Yet, during the six-week government shutdown this fall, they made subsidies a non-negotiable demand.
Trump, never one to mince words, has accused Democrats of being swayed by health insurance interests. He’s urged Republicans to bypass tax credits for insurers and send funds directly to citizens instead.
The stakes couldn’t be higher for everyday Americans caught in the healthcare quagmire. Trump’s deal with drugmakers like Bristol Myers Squibb and Gilead Sciences already stunned skeptics who thought such cuts were impossible. Now, insurers are next on the chopping block.
Critics might scoff, claiming this is just political theater. But with pharmaceutical giants bending under pressure, who’s to say insurers won’t feel the heat? Trump’s track record here suggests he’s not just blowing smoke.
Democrats, predictably, are circling the wagons around their subsidy programs. Yet, their warnings of premium spikes feel like fearmongering when families are already drowning in costs.
If this meeting happens, whether in Florida or D.C., it could redefine how healthcare operates in this country.
Insurers have long dodged accountability while premiums climb—Trump’s gamble might force their hand.
For now, Americans can only watch and wait. Will insurers buckle under presidential pressure, or will this be another standoff in the endless healthcare saga? One thing’s certain: Trump isn’t backing down without a fight.
